A Review Literature on Efficacy and Comparison between the Drugs Used in Influenza

  • Rabia Ashraf Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan
  • Hira Pervez Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan
  • Munis Mahboob Ahmed Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan
  • Fawad Ahmed Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan
  • Karun Neupane Department of Internal Medicine, Manipal College of Medical Sciences, Pokhara, Nepal https://orcid.org/0000-0001-7950-5287
Keywords: Antiviral agents, Influenza virus, Virus replication, Viral RNA

Abstract

Seasonal flu or influenza is an acute respiratory illness caused by Influenza virus A and B. The disease is usually self-limiting, but can occasionally lead to dire complications. To prevent the occurrence of these complications, many preventive, as well as therapeutic remedies, have been implicated. Vaccines have shown to reduce morbidity associated with influenza viral infection. In addition to this, if an infection does occur, it may lead to adversities, especially in patients with extremes of ages, i.e., less than 12 and more than 65. The advent of anti-viral medications has helped in a significant reduction in the symptoms associated with this disease. But, as resistance to these chemicals has emerged, this is now contributing to the widespread endemics and pandemics. With this understanding, newer and better drugs are being introduced in the market. One such medication is Baloxavir, a modified version of the novel anti-viral drugs. We conducted a thorough electronic data search on PubMed and Google Scholar. Articles were filtered using the exclusion criteria of, “co-morbid conditions,” immunodeficiency state,” “Chronic Obstructive Pulmonary Disease,” etc. The extracted articles were within a five-year time frame and were free full text. Further information was extracted using cross-references. Articles were screened for duplication. In this literature review, we describe in detail the advantages of Baloxavir to reduce the morbidity associated with Influenza infection.

Downloads

Download data is not yet available.
Abstract
266
PDF
56

Author Biography

Karun Neupane, Department of Internal Medicine, Manipal College of Medical Sciences, Pokhara, Nepal

Medical Officer

Published
2020-06-21
How to Cite
Ashraf, R., Pervez, H., Ahmed, M., Ahmed, F., & Neupane, K. (2020). A Review Literature on Efficacy and Comparison between the Drugs Used in Influenza. Journal of Nobel Medical College, 9(1), 64-70. https://doi.org/10.3126/jonmc.v9i1.29552
Section
Review Articles